Drug · CHEMBL91
MICONAZOLE
7 sourcespipelines-2026-09-18-0.3.1
Cite this record
ConductScience Library. MICONAZOLE. Drugs and targets, record CHEMBL91. Release pipelines-2026-09-18-0.3.1, 18 Sept 2026. https://conductscience.org/library/drugs/CHEMBL91
On this page
Drug
Names and IDs as ChEMBL gives them, through Open Targets.
- Open Targets' highest stage
- Approval, for 6 of its 13 diseases, from ATC, DailyMed and PMDA
- Open Targets
Targets0
The targets ChEMBL's mechanism records give for the drug, through Open Targets. A mechanism record says what the drug acts on, not how strongly.
None in this release.
Diseases13
The diseases Open Targets' clinical reports study the drug for, the most trial reports first. The stage is Open Targets', the highest any of its sources reports for the pair, and each row names the sources that report it.
1 to 10 of 13Source Open Targets
See all 13 diseasesTrials16
Trials whose record names the drug by a name ChEMBL states, posted results first, then the largest. Open Targets read each trial's text to find its drugs.
| Trial | Title | Phase | Participants | Results first posted | Named as | Linked by | Source |
|---|---|---|---|---|---|---|---|
| NCT00390780 | Efficacy and Safety Study of Miconazole Lauriad to Treat Oropharyngeal Candidiasis in HIV Patients | Phase 3 | 578 | 2013-08-29 | miconazole | Its name | ClinicalTrials.gov |
| NCT04432376 | Efficacy and Safety Study of Miconazole Oil Versus Vehicle on Fungal Infection of the Ear Canal (Otomycosis) | Phase 2/3 | 382 | 2022-11-04 | miconazole | Its name | ClinicalTrials.gov |
| NCT01230814 | Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative Women | Phase 2 | 234 | 2014-09-26 | miconazole | Its name | ClinicalTrials.gov |
| NCT01769339 | An Efficacy and Safety Study of Miconazole and Hydrocortisone Cream in the Treatment of Vulvar Candidiasis | Phase 4 | 115 | 2013-03-25 | miconazole | Its name | ClinicalTrials.gov |
| NCT03130738 | Dose-Ranging Study for Miconazole Oil for Treatment of Otomycosis | Phase 2 | 65 | 2020-05-08 | miconazole | Its name | ClinicalTrials.gov |
| NCT02185456 | Validation of a Novel Diagnostic, Prognostic Assay for Bacterial Vaginosis | Early phase 1 | 200 | miconazole | Its name | ClinicalTrials.gov | |
| NCT05660382 | Phase III Efficacy and Safety Study of Miconazole Oil for Otomycosis | Phase 3 | 112 | miconazole | Its name | ClinicalTrials.gov | |
| NCT05916729 | Use of Maqui Berry Extract in Treating Oral Candidiasis in Diabetes Mellitus Patients and Systemically Healthy Persons | Phase 4 | 90 | miconazole | Its name | ClinicalTrials.gov | |
| NCT06072716 | The Anti-fungal Effect of Miconazol Versus Miconazol-Loaded Chitosan Nanoparticles | Phase 1 | 80 | miconazole | Its name | ClinicalTrials.gov | |
| NCT01661556 | Clinical Trial of Hydroquinone Versus Miconazol in Melasma | Phase 4 | 60 | miconazole | Its name | ClinicalTrials.gov |
1 to 10 of 16
See all 16 trialsComparisons in its trials3
Comparisons Trial comparisons calculated in the trials whose record names the drug, most participants first. A comparison in one of its trials does not always compare the drug, so read the two groups.
| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| Miconazole Lauriad Buccal Tablet vs Clotrimazole Troches: Systemic Exposure of Miconazole Lauriad 50 mg Bioadhesive Buccal Tablet | 0 of 290 | 0 of 287 | 577 | NCT00390780 | Trial comparisons |
| Miconazole Lauriad Buccal Tablet vs Clotrimazole Troches: serious adverse events | 10 of 290 | 9 of 287 | 577 | NCT00390780 | Trial comparisons |
| Arm 1: Metronidazole Plus Miconazole vs Arm 2: Placebo: serious adverse events | 3 of 116 | 1 of 116 | 232 | NCT01230814 | Trial comparisons |
Papers from its trials2
The papers the trials whose record names the drug list on ClinicalTrials.gov as their results (RESULT) or as drawn from them (DERIVED), results first, newest first.
Tests in its trials0
The tests ConductCognition runs that the trials whose record names the drug name in their registered outcomes, as ScienceGraph matched them. ConductCognition's list names the tests it runs, not every test a trial used.
None in this release.
Data dates
The date of each source this release read.
Sources 7
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ConductCognition's list of its testsOur own data
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ConductCognition's list of its testsOur own data: ConductCognition's list of its tests, https://conductcognition.com
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this drug from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/drugs/v1/CHEMBL91
GET https://conductscience.org/api/drugs/v1/CHEMBL91/targets